Tcm Exim Profile
Key Indicators
- Authorised Capital ₹ 2.20 M
as on 16-06-2024
- Paid Up Capital ₹ 2.10 M
as on 16-06-2024
- Company Age 20 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.00 M
as on 16-06-2024
- Revenue 41.71%
(FY 2023)
- Profit 198.17%
(FY 2023)
- Ebitda 244.34%
(FY 2023)
- Net Worth 135.12%
(FY 2023)
- Total Assets 40.22%
(FY 2023)
About Tcm Exim
The Company is engaged in the Machinery And Equipment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.20 M and a paid-up capital of Rs 2.10 M.
The company currently has active open charges totaling ₹3.00 M.
Pragyan Pattanayak and Sushanta Shee serve as directors at the Company.
- CIN/LLPIN
U51503DL2004PTC125930
- Company No.
125930
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Apr 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Tcm Exim Private Limited offer?
Tcm Exim Private Limited offers a wide range of products and services, including Material Handling Machines & Systems, Ingredient Feeder, Lifting Hooks, Chains & Clamps, Lifting, Link and Drag Chains, Electric Motors and Components, Gear Motor, Welding Equipments & Machinery, Welding Machine, Cooling Tower, Heat Exchanger, Parts, Heat Exchangers.
Who are the key members and board of directors at Tcm Exim?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pragyan Pattanayak  | Additional Director | 23-Aug-2018 | Current |
| Sushanta Shee | Director | 24-Dec-2014 | Current |
Financial Performance and Corporate Structure Insights of Tcm Exim.
Tcm Exim Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 41.71% increase. The company also saw a substantial improvement in profitability, with a 198.17% increase in profit. The company's net worth Soared by an impressive increase of 135.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tcm Exim?
In 2023, Tcm Exim had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab National Bank Creation Date: 10 Nov 2004 | ₹3.00 M | Open |
How Many Employees Work at Tcm Exim?
Unlock and access historical data on people associated with Tcm Exim, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tcm Exim, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tcm Exim's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
